Once-monthly obesity injection shows double-digit weight loss in major clinical trial Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in adults with obesity, with or without diabetes, in a phase 2 randomized trial...

Once-monthly obesity injection shows double-digit weight loss in major clinical trial www.news-medical.net/news/2025062... #MariTide #obesity #weightloss #maridebart #cafraglutide #diabetes #innovation #health #pharma #research #GLP1 @nejm.org